Doxazosin
- Product NDC
- 0093-2069
- 11-digit product format
- 000932069
- Labeler code
- 0093
- Product ID
- 0093-2069_69a65fb3-443c-4b78-bb8b-9d8feff93fed
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA075536
- Marketing category
- ANDA
- Marketing start
- 2014-08-06
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 07a517fc-5845-3816-0f81-0a121804ec9e | Product name | 6 | 20250107 |
| 171dd63c-7eea-ede4-c010-4c25ba0a1087 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-2069-01 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-2069-01 | EA - Each | 0093-2069 | ec7f9499-7202-47ae-bda7-c67d53bdf2a5 | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 57f4a953-ad23-4a44-9956-c48aa5927132 | 12 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 57f4a953-ad23-4a44-9956-c48aa5927132 | 12 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 57f4a953-ad23-4a44-9956-c48aa5927132 | 12 |
| 197625 | doxazosin mesylate 1 MG Oral Tablet | PSN | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197627 | doxazosin mesylate 4 MG Oral Tablet | PSN | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197628 | doxazosin mesylate 8 MG Oral Tablet | PSN | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197625 | doxazosin 1 MG Oral Tablet | SCD | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197627 | doxazosin 4 MG Oral Tablet | SCD | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197628 | doxazosin 8 MG Oral Tablet | SCD | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197625 | doxazosin (as doxazosin mesylate) 1 MG Oral Tablet | SY | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197627 | doxazosin (as doxazosin mesylate) 4 MG Oral Tablet | SY | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197628 | doxazosin (as doxazosin mesylate) 8 MG Oral Tablet | SY | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 9 |
| 197626 | doxazosin mesylate 2 MG Oral Tablet | PSN | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 1 |
| 197626 | doxazosin 2 MG Oral Tablet | SCD | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 1 |
| 197626 | doxazosin (as doxazosin mesylate) 2 MG Oral Tablet | SY | 8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0093-2069-01 | 00093206901 | 100 TABLET in 1 BOTTLE (0093-2069-01) | 100 tablet | 2014-08-12 | 0000-00-00 | No | No | Current |